News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,134 Results
Type
Article (13546)
Company Profile (110)
Press Release (246478)
Section
Business (87922)
Career Advice (460)
Deals (15322)
Drug Delivery (63)
Drug Development (36517)
Employer Resources (49)
FDA (6258)
Job Trends (6181)
News (149976)
Policy (14003)
Tag
Academia (435)
Alliances (23066)
Alzheimer's disease (340)
Approvals (6248)
Artificial intelligence (54)
Bankruptcy (143)
Best Places to Work (4279)
Biosimilars (36)
Biotechnology (44)
Breast cancer (33)
Cancer (257)
Career advice (403)
Cell therapy (36)
Clinical research (30250)
Collaboration (113)
Compensation (51)
COVID-19 (745)
C-suite (34)
Data (242)
Diabetes (42)
Diagnostics (1223)
Drug pricing (54)
Earnings (31237)
Employer resources (43)
Events (36492)
Executive appointments (134)
FDA (6399)
Funding (81)
Gene therapy (55)
GLP-1 (283)
Government (1259)
Healthcare (3514)
Infectious disease (761)
Inflammatory bowel disease (45)
Interviews (57)
IPO (5794)
Job creations (2048)
Job search strategy (371)
Layoffs (166)
Legal (3406)
Lung cancer (40)
Manufacturing (75)
Medical device (1257)
Medtech (1259)
Mergers & acquisitions (9517)
Metabolic disorders (143)
Neuroscience (424)
NextGen Class of 2024 (1578)
Non-profit (589)
Northern California (337)
Obesity (91)
Opinion (107)
Patents (49)
People (28363)
Pharmaceutical (64)
Phase I (7865)
Phase II (12788)
Phase III (11500)
Pipeline (83)
Podcasts (38)
Policy (41)
Postmarket research (1399)
Preclinical (3153)
Radiopharmaceuticals (116)
Rare diseases (70)
Real estate (2629)
Regulatory (9786)
Research institute (562)
Resumes & cover letters (55)
Southern California (353)
Startups (1624)
United States (3449)
Vaccines (106)
Weight loss (72)
Date
Today (44)
Last 7 days (217)
Last 30 days (944)
Last 365 days (12927)
2024 (10491)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19034)
2019 (14886)
2018 (11713)
2017 (13890)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (37)
Asia (19711)
Australia (2546)
California (784)
Canada (530)
China (88)
Connecticut (33)
Europe (38616)
Florida (112)
Illinois (88)
Indiana (72)
Kansas (50)
Maryland (123)
Massachusetts (697)
Minnesota (46)
New Jersey (335)
New York (228)
North Carolina (255)
Northern California (337)
Ohio (35)
Pennsylvania (240)
South America (498)
Southern California (353)
Texas (108)
Washington State (59)
260,134 Results for "alkeus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
Alkeus Pharmaceuticals, Inc. today announced that Eric L. Trachtenberg, J.D., M.B.A., has joined the company as Chief Legal Officer.
May 29, 2024
·
2 min read
News
Alkeus Pharmaceuticals Announces Data Presentations at the American Academy of Ophthalmology (AAO) 2024 Annual Meeting, October 18-21 in Chicago
October 17, 2024
·
2 min read
Drug Development
Topline Results from Alkeus Pharmaceuticals’ Study of Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function Improvement
October 23, 2024
·
6 min read
Genetown
Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progression in Early-Stage Stargardt Disease Patients Treated with Gildeuretinol
Alkeus Pharmaceuticals, Inc. announced the presentation of positive interim data from its TEASE-3 study demonstrating that early-stage Stargardt disease patients treated with gildeuretinol acetate showed no disease progression and remained asymptomatic for the duration of therapy ranging between two and six years.
May 8, 2024
·
4 min read
News
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
July 16, 2024
·
2 min read
Business
Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer
Alkeus Pharmaceuticals, Inc. today announced that Seemi Khan, M.D., M.P.H., M.B.A., has joined the Company as Chief Medical Officer.
January 23, 2024
·
2 min read
Press Releases
Alkeus Pharmaceuticals Announces Results from the SAGA Study of Oral Gildeuretinol in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
September 17, 2024
·
5 min read
Genetown
Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargardt Patients During the ARVO 2024 Annual Meeting May 5-9
Alkeus Pharmaceuticals, Inc. today announced that new positive data from its TEASE-3 clinical trial of gildeuretinol in teenage and young-adult patients with early-stage Stargardt disease will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held May 5-9 in Seattle.
May 1, 2024
·
3 min read
Genetown
Alkeus Pharmaceuticals Presents Positive Interim Data Showing Gildeuretinol Halted Stargardt Disease Progression
Alkeus Pharmaceuticals, Inc., today announced positive interim data showing gildeuretinol halted Stargardt disease progression for up to six years.
January 10, 2024
·
5 min read
Business
Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO
July 3, 2024
·
3 min read
1 of 26,014
Next
